Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Immunity in Gilles de la Tourette-Syndrome: Results From a Cerebrospinal Fluid Study.

Baumgaertel C, Skripuletz T, Kronenberg J, Stangel M, Schwenkenbecher P, Sinke C, Müller-Vahl KR, Sühs KW.

Front Neurol. 2019 Jul 4;10:732. doi: 10.3389/fneur.2019.00732. eCollection 2019.

2.

Deep brain stimulation in Tourette syndrome: the known and the unknown.

Muller-Vahl KR.

J Neurol Neurosurg Psychiatry. 2019 Jul 12. pii: jnnp-2019-321008. doi: 10.1136/jnnp-2019-321008. [Epub ahead of print] No abstract available.

3.

A peek into premonitory urges in Tourette syndrome: Temporal evolution of neurophysiological oscillatory signatures.

Niccolai V, Korczok S, Finis J, Jonas M, Thomalla G, Siebner HR, Müller-Vahl K, Münchau A, Schnitzler A, Biermann-Ruben K.

Parkinsonism Relat Disord. 2019 May 31. pii: S1353-8020(19)30260-3. doi: 10.1016/j.parkreldis.2019.05.039. [Epub ahead of print]

PMID:
31182372
4.

Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.

Pringsheim T, Holler-Managan Y, Okun MS, Jankovic J, Piacentini J, Cavanna AE, Martino D, Müller-Vahl K, Woods DW, Robinson M, Jarvie E, Roessner V, Oskoui M.

Neurology. 2019 May 7;92(19):907-915. doi: 10.1212/WNL.0000000000007467.

PMID:
31061209
5.

Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.

Pringsheim T, Okun MS, Müller-Vahl K, Martino D, Jankovic J, Cavanna AE, Woods DW, Robinson M, Jarvie E, Roessner V, Oskoui M, Holler-Managan Y, Piacentini J.

Neurology. 2019 May 7;92(19):896-906. doi: 10.1212/WNL.0000000000007466.

PMID:
31061208
6.

Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies.

Yu D, Sul JH, Tsetsos F, Nawaz MS, Huang AY, Zelaya I, Illmann C, Osiecki L, Darrow SM, Hirschtritt ME, Greenberg E, Muller-Vahl KR, Stuhrmann M, Dion Y, Rouleau G, Aschauer H, Stamenkovic M, Schlögelhofer M, Sandor P, Barr CL, Grados M, Singer HS, Nöthen MM, Hebebrand J, Hinney A, King RA, Fernandez TV, Barta C, Tarnok Z, Nagy P, Depienne C, Worbe Y, Hartmann A, Budman CL, Rizzo R, Lyon GJ, McMahon WM, Batterson JR, Cath DC, Malaty IA, Okun MS, Berlin C, Woods DW, Lee PC, Jankovic J, Robertson MM, Gilbert DL, Brown LW, Coffey BJ, Dietrich A, Hoekstra PJ, Kuperman S, Zinner SH, Luðvigsson P, Sæmundsen E, Thorarensen Ó, Atzmon G, Barzilai N, Wagner M, Moessner R, Ophoff R, Pato CN, Pato MT, Knowles JA, Roffman JL, Smoller JW, Buckner RL, Willsey AJ, Tischfield JA, Heiman GA, Stefansson H, Stefansson K, Posthuma D, Cox NJ, Pauls DL, Freimer NB, Neale BM, Davis LK, Paschou P, Coppola G, Mathews CA, Scharf JM; Tourette Association of America International Consortium for Genetics, the Gilles de la Tourette GWAS Replication Initiative, the Tourette International Collaborative Genetics Study, and the Psychiatric Genomics Consortium Tourette Syndrome Working Group.

Am J Psychiatry. 2019 Mar 1;176(3):217-227. doi: 10.1176/appi.ajp.2018.18070857.

PMID:
30818990
7.

Kynurenine Is a Cerebrospinal Fluid Biomarker for Bacterial and Viral Central Nervous System Infections.

Sühs KW, Novoselova N, Kuhn M, Seegers L, Kaever V, Müller-Vahl K, Trebst C, Skripuletz T, Stangel M, Pessler F.

J Infect Dis. 2019 Jun 5;220(1):127-138. doi: 10.1093/infdis/jiz048.

PMID:
30721966
8.

Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder.

Müller-Vahl KR, Szejko N, Wilke F, Jakubovski E, Geworski L, Bengel F, Berding G.

Sci Rep. 2019 Jan 30;9(1):972. doi: 10.1038/s41598-018-37710-4.

9.

Tic disorders revisited: introduction of the term "tic spectrum disorders".

Müller-Vahl KR, Sambrani T, Jakubovski E.

Eur Child Adolesc Psychiatry. 2019 Aug;28(8):1129-1135. doi: 10.1007/s00787-018-01272-7. Epub 2019 Jan 19.

10.

Intact automatic motor inhibition in patients with tourette syndrome.

Stenner MP, Baumgaertel C, Heinze HJ, Ganos C, Müller-Vahl KR.

Mov Disord. 2018 Nov;33(11):1800-1804. doi: 10.1002/mds.27493.

PMID:
30485912
11.

Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.

Jakubovski E, Johnson JA, Nasir M, Müller-Vahl K, Bloch MH.

Depress Anxiety. 2019 Mar;36(3):198-212. doi: 10.1002/da.22854. Epub 2018 Nov 26.

PMID:
30479005
12.

Cannabinoids in functional tic-like movements.

Ganos C, Müller-Vahl K.

Parkinsonism Relat Disord. 2019 Mar;60:179-181. doi: 10.1016/j.parkreldis.2018.09.027. Epub 2018 Sep 25. No abstract available.

PMID:
30322685
13.

Pallidal and thalamic neural oscillatory patterns in tourette's syndrome.

Neumann WJ, Huebl J, Brücke C, Lofredi R, Horn A, Saryyeva A, Müller-Vahl K, Krauss JK, Kühn AA.

Ann Neurol. 2018 Oct;84(4):505-514. doi: 10.1002/ana.25311. Epub 2018 Oct 4.

PMID:
30112767
14.

European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents.

Schrag A, Martino D, Apter A, Ball J, Bartolini E, Benaroya-Milshtein N, Buttiglione M, Cardona F, Creti R, Efstratiou A, Gariup M, Georgitsi M, Hedderly T, Heyman I, Margarit I, Mir P, Moll N, Morer A, Müller N, Müller-Vahl K, Münchau A, Orefici G, Plessen KJ, Porcelli C, Paschou P, Rizzo R, Roessner V, Schwarz MJ, Steinberg T, Tagwerker Gloor F, Tarnok Z, Walitza S, Dietrich A, Hoekstra PJ; EMTICS Collaborative Group.

Eur Child Adolesc Psychiatry. 2019 Jan;28(1):91-109. doi: 10.1007/s00787-018-1190-4. Epub 2018 Jul 7.

15.

Editorial: The Neurobiology and Genetics of Gilles de la Tourette Syndrome: New Avenues through Large-Scale Collaborative Projects.

Paschou P, Müller-Vahl K.

Front Psychiatry. 2017 Oct 11;8:197. doi: 10.3389/fpsyt.2017.00197. eCollection 2017. No abstract available.

16.

Cognitive flexibility and its electrophysiological correlates in Gilles de la Tourette syndrome.

Lange F, Seer C, Müller-Vahl K, Kopp B.

Dev Cogn Neurosci. 2017 Oct;27:78-90. doi: 10.1016/j.dcn.2017.08.008. Epub 2017 Aug 18.

17.

Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients.

Jakubovski E, Müller-Vahl K.

Int J Mol Sci. 2017 Aug 10;18(8). pii: E1739. doi: 10.3390/ijms18081739.

18.

[Gilles de la Tourette Syndrome: Symptoms, Causes and Therapy].

Jakubovski E, Müller-Vahl KR.

Psychother Psychosom Med Psychol. 2017 Jun;67(6):252-268. doi: 10.1055/s-0043-103269. Epub 2017 Jun 22. Review. German.

PMID:
28722101
19.

Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome.

Huang AY, Yu D, Davis LK, Sul JH, Tsetsos F, Ramensky V, Zelaya I, Ramos EM, Osiecki L, Chen JA, McGrath LM, Illmann C, Sandor P, Barr CL, Grados M, Singer HS, Nöthen MM, Hebebrand J, King RA, Dion Y, Rouleau G, Budman CL, Depienne C, Worbe Y, Hartmann A, Müller-Vahl KR, Stuhrmann M, Aschauer H, Stamenkovic M, Schloegelhofer M, Konstantinidis A, Lyon GJ, McMahon WM, Barta C, Tarnok Z, Nagy P, Batterson JR, Rizzo R, Cath DC, Wolanczyk T, Berlin C, Malaty IA, Okun MS, Woods DW, Rees E, Pato CN, Pato MT, Knowles JA, Posthuma D, Pauls DL, Cox NJ, Neale BM, Freimer NB, Paschou P, Mathews CA, Scharf JM, Coppola G; Tourette Syndrome Association International Consortium for Genetics (TSAICG); Gilles de la Tourette Syndrome GWAS Replication Initiative (GGRI).

Neuron. 2017 Jun 21;94(6):1101-1111.e7. doi: 10.1016/j.neuron.2017.06.010.

20.

Investigation of previously implicated genetic variants in chronic tic disorders: a transmission disequilibrium test approach.

Abdulkadir M, Londono D, Gordon D, Fernandez TV, Brown LW, Cheon KA, Coffey BJ, Elzerman L, Fremer C, Fründt O, Garcia-Delgar B, Gilbert DL, Grice DE, Hedderly T, Heyman I, Hong HJ, Huyser C, Ibanez-Gomez L, Jakubovski E, Kim YK, Kim YS, Koh YJ, Kook S, Kuperman S, Leventhal B, Ludolph AG, Madruga-Garrido M, Maras A, Mir P, Morer A, Müller-Vahl K, Münchau A, Murphy TL, Plessen KJ, Roessner V, Shin EY, Song DH, Song J, Tübing J, van den Ban E, Visscher F, Wanderer S, Woods M, Zinner SH, King RA, Tischfield JA, Heiman GA, Hoekstra PJ, Dietrich A.

Eur Arch Psychiatry Clin Neurosci. 2018 Apr;268(3):301-316. doi: 10.1007/s00406-017-0808-8. Epub 2017 May 29.

21.

Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols.

Kanaan AS, Jakubovski E, Müller-Vahl K.

Brain Sci. 2017 Apr 26;7(5). pii: E47. doi: 10.3390/brainsci7050047.

22.

The human globus pallidus internus is sensitive to rewards - Evidence from intracerebral recordings.

Münte TF, Marco-Pallares J, Bolat S, Heldmann M, Lütjens G, Nager W, Müller-Vahl K, Krauss JK.

Brain Stimul. 2017 May - Jun;10(3):657-663. doi: 10.1016/j.brs.2017.01.004. Epub 2017 Feb 14.

PMID:
28254363
23.

Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome.

Kanaan AS, Gerasch S, García-García I, Lampe L, Pampel A, Anwander A, Near J, Möller HE, Müller-Vahl K.

Brain. 2017 Jan;140(1):218-234. doi: 10.1093/brain/aww285. Epub 2016 Dec 22.

PMID:
28007998
24.

Gilles de la Tourette syndrome is associated with hypermethylation of the dopamine D2 receptor gene.

Müller-Vahl KR, Loeber G, Kotsiari A, Müller-Engling L, Frieling H.

J Psychiatr Res. 2017 Mar;86:1-8. doi: 10.1016/j.jpsychires.2016.11.004. Epub 2016 Nov 12.

25.

"I swear it is Tourette's!": On functional coprolalia and other tic-like vocalizations.

Ganos C, Edwards MJ, Müller-Vahl K.

Psychiatry Res. 2016 Dec 30;246:821-826. doi: 10.1016/j.psychres.2016.10.021. Epub 2016 Oct 17.

26.

Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome.

Gerasch S, Kanaan AS, Jakubovski E, Müller-Vahl KR.

Front Neurosci. 2016 Sep 12;10:416. doi: 10.3389/fnins.2016.00416. eCollection 2016.

27.

New Insights into Clinical Characteristics of Gilles de la Tourette Syndrome: Findings in 1032 Patients from a Single German Center.

Sambrani T, Jakubovski E, Müller-Vahl KR.

Front Neurosci. 2016 Sep 12;10:415. doi: 10.3389/fnins.2016.00415. eCollection 2016.

28.

TS-EUROTRAIN: A European-Wide Investigation and Training Network on the Etiology and Pathophysiology of Gilles de la Tourette Syndrome.

Forde NJ, Kanaan AS, Widomska J, Padmanabhuni SS, Nespoli E, Alexander J, Rodriguez Arranz JI, Fan S, Houssari R, Nawaz MS, Rizzo F, Pagliaroli L, Zilhäo NR, Aranyi T, Barta C, Boeckers TM, Boomsma DI, Buisman WR, Buitelaar JK, Cath D, Dietrich A, Driessen N, Drineas P, Dunlap M, Gerasch S, Glennon J, Hengerer B, van den Heuvel OA, Jespersgaard C, Möller HE, Müller-Vahl KR, Openneer TJ, Poelmans G, Pouwels PJ, Scharf JM, Stefansson H, Tümer Z, Veltman DJ, van der Werf YD, Hoekstra PJ, Ludolph A, Paschou P.

Front Neurosci. 2016 Aug 23;10:384. doi: 10.3389/fnins.2016.00384. eCollection 2016.

29.

Effect of Deep Brain Stimulation on Regional Cerebral Blood Flow in Patients with Medically Refractory Tourette Syndrome.

Haense C, Müller-Vahl KR, Wilke F, Schrader C, Capelle HH, Geworski L, Bengel FM, Krauss JK, Berding G.

Front Psychiatry. 2016 Jul 5;7:118. doi: 10.3389/fpsyt.2016.00118. eCollection 2016.

30.

The ONLINE-TICS Study Protocol: A Randomized Observer-Blind Clinical Trial to Demonstrate the Efficacy and Safety of Internet-Delivered Behavioral Treatment for Adults with Chronic Tic Disorders.

Jakubovski E, Reichert C, Karch A, Buddensiek N, Breuer D, Müller-Vahl K.

Front Psychiatry. 2016 Jun 30;7:119. doi: 10.3389/fpsyt.2016.00119. eCollection 2016.

31.

Refractoriness to pharmacological treatment for tics: A multicentre European audit.

Macerollo A, Martino D, Cavanna AE, Gulisano M, Hartmann A, Hoekstra PJ, Hedderly T, Debes NM, Muller-Vahl K, Neuner I, Porta M, Rickards H, Rizzo R, Cardona F, Roessner V.

J Neurol Sci. 2016 Jul 15;366:136-138. doi: 10.1016/j.jns.2016.05.004. Epub 2016 May 4. No abstract available.

PMID:
27288792
32.

Increased beta rhythm as an indicator of inhibitory mechanisms in tourette syndrome.

Niccolai V, van Dijk H, Franzkowiak S, Finis J, Südmeyer M, Jonas M, Thomalla G, Siebner HR, Müller-Vahl K, Münchau A, Schnitzler A, Biermann-Ruben K.

Mov Disord. 2016 Mar;31(3):384-92. doi: 10.1002/mds.26454. Epub 2015 Dec 9.

PMID:
26649991
33.

Narcissistic vulnerability is a common cause for depression in patients with Gilles de la Tourette syndrome.

Trillini MO, Müller-Vahl KR.

Psychiatry Res. 2015 Dec 15;230(2):695-703. doi: 10.1016/j.psychres.2015.10.030. Epub 2015 Oct 30.

PMID:
26548979
34.

Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies.

Sühs KW, Skripuletz T, Pul R, Alvermann S, Schwenkenbecher P, Stangel M, Müller-Vahl K.

Mol Brain. 2015 Oct 13;8(1):62. doi: 10.1186/s13041-015-0154-6.

35.

Association of AADAC Deletion and Gilles de la Tourette Syndrome in a Large European Cohort.

Bertelsen B, Stefánsson H, Riff Jensen L, Melchior L, Mol Debes N, Groth C, Skov L, Werge T, Karagiannidis I, Tarnok Z, Barta C, Nagy P, Farkas L, Brøndum-Nielsen K, Rizzo R, Gulisano M, Rujescu D, Kiemeney LA, Tosato S, Nawaz MS, Ingason A, Unnsteinsdottir U, Steinberg S, Ludvigsson P, Stefansson K, Kuss AW, Paschou P, Cath D, Hoekstra PJ, Müller-Vahl K, Stuhrmann M, Silahtaroglu A, Pfundt R, Tümer Z.

Biol Psychiatry. 2016 Mar 1;79(5):383-391. doi: 10.1016/j.biopsych.2015.08.027. Epub 2015 Sep 3.

PMID:
26444075
36.

Blocking Phenomena in Gilles de la Tourette Syndrome.

Ganos C, Müller-Vahl K, Bhatia KP.

Mov Disord Clin Pract. 2015 Jun 30;2(4):438-439. doi: 10.1002/mdc3.12199. eCollection 2015 Dec. No abstract available.

37.

Patients with Gilles de la Tourette syndrome have widespread personality differences.

Trillini MO, Müller-Vahl KR.

Psychiatry Res. 2015 Aug 30;228(3):765-73. doi: 10.1016/j.psychres.2015.04.043. Epub 2015 May 29.

PMID:
26112450
38.

Obsessive-compulsive disorder is a heterogeneous disorder: evidence from diffusion tensor imaging and magnetization transfer imaging.

Glahn A, Prell T, Grosskreutz J, Peschel T, Müller-Vahl KR.

BMC Psychiatry. 2015 Jun 25;15:135. doi: 10.1186/s12888-015-0535-5.

39.

Severe self-injurious behavior with teeth extraction in a boy with Tourette syndrome.

Krüger D, Müller-Vahl KR.

Pediatr Neurol. 2015 May;52(5):e5. doi: 10.1016/j.pediatrneurol.2015.02.003. Epub 2015 Feb 11. No abstract available.

PMID:
25765463
40.

Comparative characterization of single cell activity in the globus pallidus internus of patients with dystonia or Tourette syndrome.

Alam M, Schwabe K, Lütjens G, Capelle HH, Manu M, von Wrangel C, Müller-Vahl K, Schrader C, Scheinichen D, Blahak C, Heissler HE, Krauss JK.

J Neural Transm (Vienna). 2015 May;122(5):687-99. doi: 10.1007/s00702-014-1277-0. Epub 2014 Aug 1.

PMID:
25081018
41.

Can tics be performed convincingly by an actor?

Müller-Vahl KR, Riemann L, Krämer H, Münchau A.

Behav Neurol. 2014;2014:893859. doi: 10.1155/2014/893859. Epub 2014 May 7.

42.

Tourette patients' misbelief of a tic rebound is due to overall difficulties in reliable tic rating.

Müller-Vahl KR, Riemann L, Bokemeyer S.

J Psychosom Res. 2014 Jun;76(6):472-6. doi: 10.1016/j.jpsychores.2014.03.003. Epub 2014 Mar 24.

PMID:
24840142
43.

[Tourette syndrome and other tic disorders in DSM-5 – a comment].

Roessner V, Ludolph AG, Müller-Vahl K, Neuner I, Rothenberger A, Woitecki K, Münchau A.

Z Kinder Jugendpsychiatr Psychother. 2014 Mar;42(2):129-34. doi: 10.1024/1422-4917/a000280. German.

PMID:
24571819
44.

Tics are caused by alterations in prefrontal areas, thalamus and putamen, while changes in the cingulate gyrus reflect secondary compensatory mechanisms.

Müller-Vahl KR, Grosskreutz J, Prell T, Kaufmann J, Bodammer N, Peschel T.

BMC Neurosci. 2014 Jan 7;15:6. doi: 10.1186/1471-2202-15-6.

45.

Altered intrahemispheric structural connectivity in Gilles de la Tourette syndrome.

Cheng B, Braass H, Ganos C, Treszl A, Biermann-Ruben K, Hummel FC, Müller-Vahl K, Schnitzler A, Gerloff C, Münchau A, Thomalla G.

Neuroimage Clin. 2013 Dec 7;4:174-81. doi: 10.1016/j.nicl.2013.11.011. eCollection 2014.

46.

Costs of control: decreased motor cortex engagement during a Go/NoGo task in Tourette's syndrome.

Thomalla G, Jonas M, Bäumer T, Siebner HR, Biermann-Ruben K, Ganos C, Orth M, Hummel FC, Gerloff C, Müller-Vahl K, Schnitzler A, Münchau A.

Brain. 2014 Jan;137(Pt 1):122-36. doi: 10.1093/brain/awt288. Epub 2013 Oct 30.

PMID:
24176975
47.

The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms.

Hazekamp A, Ware MA, Muller-Vahl KR, Abrams D, Grotenhermen F.

J Psychoactive Drugs. 2013 Jul-Aug;45(3):199-210.

PMID:
24175484
48.

In reply.

Ludolph A, Roessner V, Münchau A, Müller-Vahl K.

Dtsch Arztebl Int. 2013 Apr;110(16):285. doi: 10.3238/arztebl.2013.0285b. No abstract available.

49.

Cannabis therapy.

Müller-Vahl K, Grotenhermen F.

Dtsch Arztebl Int. 2013 Mar;110(9):144. doi: 10.3238/arztebl.2013.0144a. Epub 2013 Mar 1. No abstract available.

50.

In reply.

Müller-Vahl K.

Dtsch Arztebl Int. 2013 Mar;110(10):175. doi: 10.3238/arztebl.2013.0175. Epub 2013 Mar 8. No abstract available.

Supplemental Content

Loading ...
Support Center